Microgestin 1/20 side effects by duration, gender and age - a phase IV clinical study of FDA data

Summary:

Side effects are reported by people who take Microgestin 1/20. Common side effects include acne cystic among females.

The phase IV clinical study is created by eHealthMe based on 30 reports from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

With medical big data and AI algorithms, eHealthMe enables everyone to run phase IV clinical trial to detect adverse drug outcomes and monitor effectiveness. Our original studies have been referenced on 600+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Most recently, phase IV clinial trails for COVID 19 vaccines have been added, check here.



On Jun, 08, 2022

30 people who take Microgestin 1/20 and have side effects are studied.


What is Microgestin 1/20?

Microgestin 1/20 has active ingredients of ethinyl estradiol; norethindrone acetate. It is often used in birth control. eHealthMe is studying from 145 Microgestin 1/20 users for its effectiveness, alternative drugs and more.

Number of Microgestin 1/20 reports submitted per year:

Microgestin 1/20 side effects.

Microgestin 1/20 side effects by time on the drug*:

< 1 month:

  1. Alopecia (absence of hair from areas of the body)
  2. Vaginal haemorrhage (vaginal bleeding)
  3. Vision blurred

1 - 6 months:

  1. Blister (small pocket of fluid within the upper layers of the skin caused by forceful rubbing (friction), burning, freezing, chemical exposure)
  2. Menorrhagia (an abnormally heavy bleeding and prolonged menstrual period at regular intervals)
  3. Pregnancy on oral contraceptive
  4. Pulmonary embolism (blockage of the main artery of the lung)

6 - 12 months:

  1. Colitis ischaemic (due to infection of intestine impaired blood supply to colon)

1 - 2 years:

  1. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
  2. Transient ischaemic attack (a transient episode of neurologic dysfunction caused by ischemia (loss of blood flow))

2 - 5 years:

n/a

5 - 10 years:

n/a

10+ years:

n/a

not specified:

  1. Acne cystic (skin problems that cause pimples)
  2. Abortion induced (medically referred abortion)
  3. Acne (skin problems that cause pimples)
  4. Activities of daily living impaired
  5. Amenorrhoea (absence of a menstrual period in a woman of reproductive age)
  6. Application site discolouration
  7. Autoimmune thyroiditis (form of thyroiditis associated with an autoimmune disease)
  8. Coeliac disease (simple food intolerance)
  9. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
  10. Drug intolerance (drug sensitivity)

Microgestin 1/20 side effects by gender *:

female:

  1. Acne cystic (skin problems that cause pimples)
  2. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
  3. Coeliac disease (simple food intolerance)
  4. Colitis ischaemic (due to infection of intestine impaired blood supply to colon)
  5. Feeling abnormal
  6. Haematochezia (passage of stools containing blood)
  7. Menorrhagia (an abnormally heavy bleeding and prolonged menstrual period at regular intervals)
  8. Menstruation irregular
  9. Metrorrhagia (uterine bleeding at irregular intervals)
  10. Pregnancy on oral contraceptive

male:

n/a

Microgestin 1/20 side effects by age (0-1 to 60+) *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Vaginal discharge
  2. Vaginal haemorrhage (vaginal bleeding)

20-29:

  1. Acne (skin problems that cause pimples)
  2. Alopecia (absence of hair from areas of the body)
  3. Amenorrhoea (absence of a menstrual period in a woman of reproductive age)
  4. Blister (small pocket of fluid within the upper layers of the skin caused by forceful rubbing (friction), burning, freezing, chemical exposure)
  5. Feeling abnormal
  6. Menstruation irregular
  7. Pregnancy on oral contraceptive
  8. Pyelonephritis (inflammation of kidney caused by bacteria)
  9. Skin disorder (skin disease)
  10. Transient ischaemic attack (a transient episode of neurologic dysfunction caused by ischemia (loss of blood flow))

30-39:

  1. Abortion induced (medically referred abortion)
  2. Activities of daily living impaired
  3. Colitis ischaemic (due to infection of intestine impaired blood supply to colon)
  4. Pulmonary embolism (blockage of the main artery of the lung)
  5. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)

40-49:

  1. Acne cystic (skin problems that cause pimples)
  2. Application site discolouration
  3. Autoimmune thyroiditis (form of thyroiditis associated with an autoimmune disease)
  4. Menorrhagia (an abnormally heavy bleeding and prolonged menstrual period at regular intervals)

50-59:

n/a

60+:

n/a

* Approximation only. Some reports may have incomplete information.

Do you take Microgestin 1/20?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



How the study uses the data?

The study is based on ethinyl estradiol; norethindrone acetate (the active ingredients of Microgestin 1/20) and Microgestin 1/20 (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered.

Related studies

Alternative drugs to, pros and cons of Microgestin 1/20:

All Microgestin 1/20 side effects from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: